Adial pharmaceuticals to present at the winter wrap-up microcap rodeo conference on february 20

Charlottesville, va / accesswire / february 15, 2024 / adial pharmaceuticals, inc. (nasdaq:adil)(nasdaq:adilw) ("adial" or the "company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will be participating in the winter wrap-up microcap rodeo conference, which will be held virtually tuesday, february 20 through friday, february 23, 2024. cary claiborne, chief executive officer of adial, is scheduled to present on tuesday, february 20 at 11:30 a.m.
ADIL Ratings Summary
ADIL Quant Ranking